The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 7355033 B1

PDF
Full Text
Expired
Date of Patent:
Apr. 08, 2008

Filed:

Nov. 13, 2003
Applicants:

Pei-yong Shi, Albany, NY (US);

Michael Lo, Albany, NY (US);

Mark Tilgner, Albany, NY (US);

Inventors:

Pei-Yong Shi, Albany, NY (US);

Michael Lo, Albany, NY (US);

Mark Tilgner, Albany, NY (US);

Assignee:

Health Research, Inc., Rensselaer, NY (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/40 (2006.01); C12N 5/10 (2006.01); C12Q 1/18 (2006.01);
U.S. Cl.
CPC ...
Abstract

The instant invention provides stable and novel lineage I WNV reverse genetics systems, and methods for making the reverse genetics systems, specifically, a fully-infectious lineage I WNV cDNA or replicon system engineered with one or more nucleotide sequences each encoding a reporter gene to be used in high throughput cell-based screening assays for the identification of novel antiflaviviral chemotherapeutics and/or vaccines effective to treat and/or immunize against infections by WNV and other emerging flaviviruses, such as, for example, JEV, SLEV, AV, KV, JV, CV, YV, TBEV, DENV-1, DENV-2, DENV-3, DENV-4, YFV and MVEV. The present invention further provides methods of high throughput screening of antiflaviviral compounds or improved derivatives thereof using novel lineage I WNV reverse genetics systems and/or cell lines stably containing the reverse genetics systems. Also, the invention provides novel pharmaceutical compositions comprising an attenuated lineage I WNV that is less virulent but similarly immunogenic as the parent WNV and is capable of providing a protective immune response in a host.


Find Patent Forward Citations

Shi, Pei-Yong. (2008). Screening for west nile virus antiviral therapy (U.S. Patent No. 7355033). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/7355033

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…